Search for Clinical Trial Results
Anemia, Sickle Cell - 544 Studies Found
Status | Study |
Terminated |
Study Name: Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository) Condition: Anemia, Sickle Cell Date: 2007-09-10 |
Completed |
Study Name: Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease Condition: Sickle Cell Disease Date: 2010-03-25 |
Completed |
Study Name: PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease Condition: Sickle Cell Disease Date: 2006-06-21 Interventions: Drug: L-citrulline tablets, 1000 mg |
Completed |
Study Name: Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease Condition: Sickle Cell Disease Date: 2009-05-27 Interventions: Drug: GMI-1070 Intravenous GMI-1070 given as two doses over the course of one day |
Recruiting |
Study Name: Sickle Cell Disease Biofluid Chip Technology (SCD BioChip) Condition: Sickle Cell Disease Date: 2015-05-27 Interventions: Other: SCD Group No Intervention. Use of discard blood/tissue |
Terminated |
Study Name: A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy Condition:
|
Recruiting |
Study Name: SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge Condition: Sickle Cell Disease Date: 2015-06-17 Interventions: Device: SMART app Subjects assigned to the intervention group will be given the pre-programmed SMART app |
Active, not recruiting |
Study Name: Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) Condition: Sickle Cell Disease Date: 2008-08-29 Interventions: Biological: Hematopoietic Stem Cell Transplantation The st |
Completed |
Study Name: Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease Condition: Sickle Cell Disease Date: 2008-10-27 Interventions: Drug: Hydroxycarbamide, Hydroxyurea (drug) hydroxyurea 20-25 mg/kg/day since at least 3 months |
Completed |
Study Name: Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD) Condition: Sickle Cell Disease Date: 2013-02-01 Interventions: Drug: NKTT120 |